NCT03093116 2026-05-27TRIDENT-1Turning Point Therapeutics, Inc.Phase 1/2 Recruiting500 enrolled 2 FDA
NCT07164313 2026-05-07A Study of ZW251 in Participants With Advanced Solid TumorsZymeworks BC Inc.Phase 1 Recruiting100 enrolled